This brand name is authorized in Austria, Canada, Cyprus, Estonia, Spain, Finland, France, Croatia, Ireland, Israel, Italy, Lithuania, Poland, United Kingdom
The drug MINJUVI contains one active pharmaceutical ingredient (API):
|
1
Tafasitamab
UNII QQA9MLH692 - TAFASITAMAB
|
|
Tafasitamab is an Fc-enhanced monoclonal antibody that targets the CD19 antigen expressed on the surface of pre-B and mature B lymphocytes. Upon binding to CD19, tafasitamab mediates B-cell lysis. The Fc modification results in enhanced antibody-dependent cellular cytotoxicity and antibody-dependent cellular phagocytosis. |
Below package inserts are available for further reading:
| Title | Information Source | Document Type | |
|---|---|---|---|
| MINJUVI Powder for concentrate for solution for infusion | European Medicines Agency (EU) | MPI, EU: SmPC |
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
| ATC code | Group title | Classification |
|---|---|---|
| L01FX12 | Tafasitamab | L Antineoplastic and immunomodulating agents → L01 Antineoplastic agents → L01F Monoclonal antibodies and antibody drug conjugates → L01FX Other monoclonal antibodies |
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| Country: CA | Health Products and Food Branch | Identifier(s): 02518627 |
| Country: EE | Ravimiamet | Identifier(s): 1861185 |
| Country: ES | Centro de información online de medicamentos de la AEMPS | Identifier(s): 1211570001 |
| Country: FI | Lääkealan turvallisuus- ja kehittämiskeskus | Identifier(s): 121344 |
| Country: FR | Base de données publique des médicaments | Identifier(s): 65488266 |
| Country: IL | מִשְׂרַד הַבְּרִיאוּת | Identifier(s): 9021 |
| Country: IT | Agenzia del Farmaco | Identifier(s): 049606015 |
| Country: LT | Valstybinė vaistų kontrolės tarnyba | Identifier(s): 1093289 |
| Country: PL | Rejestru Produktów Leczniczych | Identifier(s): 100457769 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
